02164nas a2200289 4500008004100000022001400041245017000055210006900225260000900294300000800303490000600311520111200317100002701429700001601456700002901472700002601501700002901527700001901556700002101575700002901596700002701625700002001652700002401672700002401696700002601720856012801746 2014 eng d a2234-943X00aThe Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.0 aActivation of the Sox2 RR2 Pluripotency Transcriptional Reporter c2014 a3080 v43 a
The striking similarity displayed at the mechanistic level between tumorigenesis and the generation of induced pluripotent stem cells and the fact that genes and pathways relevant for embryonic development are reactivated during tumor progression highlights the link between pluripotency and cancer. Based on these observations, we tested whether it is possible to use a pluripotency-associated transcriptional reporter, whose activation is driven by the SRR2 enhancer from the Sox2 gene promoter (named S4+ reporter), to isolate cancer stem cells (CSCs) from breast cancer cell lines. The S4+ pluripotency transcriptional reporter allows the isolation of cells with enhanced tumorigenic potential and its activation was switched on and off in the cell lines studied, reflecting a plastic cellular process. Microarray analysis comparing the populations in which the reporter construct is active versus inactive showed that positive cells expressed higher mRNA levels of cytokines (IL-8, IL-6, TNF) and genes (such as ATF3, SNAI2, and KLF6) previously related with the CSC phenotype in breast cancer.
1 aIglesias, Juan, Manuel1 aLeis, Olatz1 aRuiz, Estíbaliz, Pérez1 aBarrie, Juan, Gumuzio1 aGarcia-Garcia, Francisco1 aAduriz, Ariane1 aBeloqui, Izaskun1 aHernandez-Garcia, Susana1 aLopez-Mato, Maria, Paz1 aDopazo, Joaquin1 aPandiella, Atanasio1 aMenendez, Javier, A1 aMartin, Angel, Garcia uhttps://clinbioinfosspa.es/content/activation-sox2-rr2-pluripotency-transcriptional-reporter-human-breast-cancer-cell-lines